NASDAQ:LFCR Lifecore Biomedical (LFCR) Stock Price, News & Analysis $6.81 -0.39 (-5.42%) Closing price 04:00 PM EasternExtended Trading$6.84 +0.04 (+0.51%) As of 07:23 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Lifecore Biomedical Stock (NASDAQ:LFCR) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Lifecore Biomedical alerts:Sign Up Key Stats Today's Range$6.74▼$7.0550-Day Range$5.60▼$7.2052-Week Range$3.68▼$7.99Volume293,645 shsAverage Volume217,011 shsMarket Capitalization$252.14 millionP/E RatioN/ADividend YieldN/APrice Target$8.00Consensus RatingHold Company OverviewLifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States and internationally. The company engages in the manufacturing of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, such as technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.Read More… Remove Ads Lifecore Biomedical Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks26th Percentile Overall ScoreLFCR MarketRank™: Lifecore Biomedical scored higher than 26% of companies evaluated by MarketBeat, and ranked 839th out of 916 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.2 / 5Analyst RatingHold Consensus RatingLifecore Biomedical has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on 1 buy rating, 2 hold ratings, and no sell ratings.Amount of Analyst CoverageLifecore Biomedical has only been the subject of 1 research reports in the past 90 days.Read more about Lifecore Biomedical's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Lifecore Biomedical are expected to grow in the coming year, from ($0.91) to ($0.60) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Lifecore Biomedical is -12.16, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Lifecore Biomedical is -12.16, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioLifecore Biomedical has a P/B Ratio of 18.41. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Lifecore Biomedical's valuation and earnings. Short Interest0.0 / 5Short Interest LevelBearish Percentage of Shares Shorted7.49% of the float of Lifecore Biomedical has been sold short.Short Interest Ratio / Days to CoverLifecore Biomedical has a short interest ratio ("days to cover") of 11.2, which indicates bearish sentiment.Change versus previous monthShort interest in Lifecore Biomedical has recently increased by 2.93%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldLifecore Biomedical does not currently pay a dividend.Dividend GrowthLifecore Biomedical does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted7.49% of the float of Lifecore Biomedical has been sold short.Short Interest Ratio / Days to CoverLifecore Biomedical has a short interest ratio ("days to cover") of 11.2, which indicates bearish sentiment.Change versus previous monthShort interest in Lifecore Biomedical has recently increased by 2.93%, indicating that investor sentiment is decreasing. News and Social Media1.5 / 5News Sentiment-0.27 News SentimentLifecore Biomedical has a news sentiment score of -0.27. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.60 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 8 news articles for Lifecore Biomedical this week, compared to 4 articles on an average week.MarketBeat Follows2 people have added Lifecore Biomedical to their MarketBeat watchlist in the last 30 days. Company Ownership5.0 / 5Insider TradingAcquiring Shares Insider Buying vs. Insider SellingIn the past three months, Lifecore Biomedical insiders have bought more of their company's stock than they have sold. Specifically, they have bought $97,580.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders32.20% of the stock of Lifecore Biomedical is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions83.36% of the stock of Lifecore Biomedical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Lifecore Biomedical's insider trading history. Receive LFCR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Lifecore Biomedical and its competitors with MarketBeat's FREE daily newsletter. Email Address LFCR Stock News HeadlinesLifecore Biomedical targets 12% revenue CAGR and expanded CDMO pipeline by 2027April 3 at 9:29 PM | msn.comLifecore Biomedical, Inc. (LFCR) Q3 2025 Earnings Call TranscriptApril 3 at 8:01 PM | seekingalpha.comTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.April 3, 2025 | Porter & Company (Ad)Lifecore Biomedical Reports Third Quarter Fiscal 2025 Financial Results and Provides Corporate UpdateApril 3 at 4:05 PM | globenewswire.comLifecore Biomedical (LFCR) Expected to Announce Earnings on ThursdayApril 2 at 1:23 AM | americanbankingnews.comCraig-Hallum Keeps Their Buy Rating on Lifecore Biomedical (LFCR)April 1 at 2:45 AM | markets.businessinsider.comLifecore Biomedical to Report Financial Results for Third Quarter of Fiscal 2025 on April 3, 2025March 27, 2025 | globenewswire.comHumanetics Selects Lifecore Biomedical to Deliver CDMO Services Supporting Development of BIO 300 for the Prevention of Acute Radiation SyndromeMarch 17, 2025 | finance.yahoo.comSee More Headlines LFCR Stock Analysis - Frequently Asked Questions How have LFCR shares performed this year? Lifecore Biomedical's stock was trading at $7.43 at the beginning of 2025. Since then, LFCR shares have decreased by 8.3% and is now trading at $6.81. View the best growth stocks for 2025 here. How were Lifecore Biomedical's earnings last quarter? Lifecore Biomedical, Inc. (NASDAQ:LFCR) released its earnings results on Thursday, April, 3rd. The company reported ($0.19) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.14) by $0.05. Lifecore Biomedical had a negative trailing twelve-month return on equity of 315.23% and a negative net margin of 12.52%. Who are Lifecore Biomedical's major shareholders? Top institutional shareholders of Lifecore Biomedical include MassMutual Private Wealth & Trust FSB (0.01%). Insiders that own company stock include Wynnefield Partners Small Cap and Paul Josephs. View institutional ownership trends. How do I buy shares of Lifecore Biomedical? Shares of LFCR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Lifecore Biomedical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Lifecore Biomedical investors own include JPMorgan Chase & Co. (JPM), Advanced Micro Devices (AMD), Tesla (TSLA), Meta Platforms (META), NVIDIA (NVDA), Netflix (NFLX) and Visa (V). Company Calendar Today4/03/2025Last Earnings4/03/2025Next Earnings (Estimated)4/03/2025Fiscal Year End5/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:LFCR CIK1005286 Webwww.lifecore.com Phone(800) 454-1355Fax650-368-9818Employees690Year FoundedN/APrice Target and Rating Average Stock Price Target$8.00 High Stock Price Target$10.00 Low Stock Price Target$6.00 Potential Upside/Downside+17.5%Consensus RatingHold Rating Score (0-4)2.33 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)($0.56) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$12.01 million Net Margins-12.52% Pretax Margin-11.40% Return on Equity-315.23% Return on Assets-12.74% Debt Debt-to-Equity Ratio9.21 Current Ratio2.32 Quick Ratio1.21 Sales & Book Value Annual Sales$130.86 million Price / Sales1.93 Cash FlowN/A Price / Cash FlowN/A Book Value$0.37 per share Price / Book18.41Miscellaneous Outstanding Shares37,025,000Free Float26,580,000Market Cap$252.14 million OptionableOptionable Beta0.96 7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free Report This page (NASDAQ:LFCR) was last updated on 4/3/2025 by MarketBeat.com Staff From Our Partners“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredNew “Trump” currency proposed in DCAfter a massive run-up – tech stocks are crashing. And as you’d suspect, the rich and powerful got out firs...Paradigm Press | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lifecore Biomedical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lifecore Biomedical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.